Biologicals first-line in chronic inflammatory bowel disease? Yes

被引：0
|
作者：
Stallmach, A. [1 ]
机构：
[1] Univ Jena, Abt Gastroenterol Hepatol & Infektiol, Klin Innere Med 2, D-07740 Jena, Germany
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2011年 / 136卷 / 36期
关键词：
chronic inflammatory bowel disease; biologicals; first-line therapy; THERAPY;
D O I：
10.1055/s-0031-1286102
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1788 / 1788
页数：1
相关论文
共 50 条
  • [1] Biologicals first-line in chronic inflammatory bowel disease? No
    Herrlinger, K.
    Stange, E. F.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2011, 136 (36) : 1789 - 1789
  • [2] First-Line Therapies in Inflammatory Bowel Disease
    Girardin, Marc
    Manz, Michael
    Manser, Christine
    Biedermann, Luc
    Wanner, Roger
    Frei, Pascal
    Safroneeva, Ekaterina
    Mottet, Christian
    Rogler, Gerhard
    Schoepfer, Alain M.
    DIGESTION, 2012, 86 : 6 - 10
  • [3] Characteristics and First-Line Treatments of Patients With Pyoderma Gangrenosum and Inflammatory Bowel Disease
    Kek, Laura
    Calderon, Gerardo
    Coelho-Prabhu, Nayantara
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S914 - S915
  • [4] First-Line Biologics or Small Molecules in Inflammatory Bowel Disease: a Practical Guide for the Clinician
    Chang S.
    Hudesman D.
    Current Gastroenterology Reports, 2020, 22 (2)
  • [5] The Effectiveness and Safety of First-Line Thioguanine in Thiopurine-Naive Inflammatory Bowel Disease Patients
    Crouwel, Femke
    Bayoumy, Ahmed B.
    Mulder, Chris J. J.
    Peters, Job H. C.
    Boekema, Paul J.
    Derijks, Luc J. J.
    de Boer, Sybrand Y.
    van de Meeberg, Paul C.
    Ahmad, Ishfaq
    Buiter, Hans J. C.
    de Boer, Nanne K.
    INFLAMMATORY BOWEL DISEASES, 2023, 30 (09) : 1492 - 1499
  • [6] Interleukin-23 Blockers: Born to be First-line Biologic Agents in Inflammatory Bowel Disease?
    Argollo, Marjorie C.
    Allocca, Mariangela
    Furfaro, Federica
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    CURRENT PHARMACEUTICAL DESIGN, 2019, 25 (01) : 25 - 31
  • [7] Azathioprine with Allopurinol Is a Promising First-Line Therapy for Inflammatory Bowel Diseases
    van Liere, Elsa L. S. A.
    Bayoumy, Ahmed B.
    Mulder, Chris J. J.
    Warner, Ben
    Hayee, Bu
    Mateen, Bilal A.
    Nolan, Jonathan D.
    de Boer, Nanne K. H.
    Anderson, Simon H. C.
    Ansari, Azhar R.
    DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (08) : 4008 - 4019
  • [8] Azathioprine with Allopurinol Is a Promising First-Line Therapy for Inflammatory Bowel Diseases
    Elsa L. S. A. van Liere
    Ahmed B. Bayoumy
    Chris J. J. Mulder
    Ben Warner
    Bu Hayee
    Bilal A. Mateen
    Jonathan D. Nolan
    Nanne K. H. de Boer
    Simon H. C. Anderson
    Azhar R. Ansari
    Digestive Diseases and Sciences, 2022, 67 : 4008 - 4019
  • [9] Vedolizumab as the First-Line of Biologicals for Pediatric Patients With Ulcerative Colitis
    Kakiuchi, Toshihiko
    Yoshiura, Masato
    CLINICAL THERAPEUTICS, 2022, 44 (07) : 1028 - 1032
  • [10] Influence of comorbidities on treatment considerations for first-line biologic prescribing in patients with inflammatory bowel disease in the UK
    Akbar, Ayesha
    Orchard, Tim
    Powell, Nick
    Selinger, Christian
    Tibbatts, Clare
    FRONTLINE GASTROENTEROLOGY, 2022, 13 (06) : 490 - 496
12345